GCG and metabolic dysfunction-associated steatotic liver disease: Specifically, nearly 35% of subjects (n = 29/81) with grade 1 NAFLD had elevated plasma glucagon levels as compared to subjects (n = 5/81) with grade 2 NAFLD (6.1%).